KOBOCommodity Chemicals
Kobo Biotech Ltd — Cash Flow Statement
₹2.23
+1.30%
Kobo Biotech Ltd Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Free Cash Flow | 0.20 Cr | 0.87 Cr | 93.76 Cr | 2.51 Cr |
| Issuance Of Debt | 0.80 Cr | 0.00 | — | 11.16 Cr |
| End Cash Position | 0.18 Cr | 0.13 Cr | 0.13 Cr | 1.56 Cr |
| Beginning Cash Position | 0.13 Cr | 0.13 Cr | 1.56 Cr | 0.13 Cr |
| Changes In Cash | 0.05 Cr | 6000.00 | -1.43 Cr | 1.43 Cr |
| Financing Cash Flow | -0.15 Cr | -0.87 Cr | -120.28 Cr | -1.08 Cr |
| Net Other Financing Charges | -0.95 Cr | -0.87 Cr | -0.33 Cr | 1000.00 |
| Interest Paid Cff | 0.00 | 0.00 | -0.13 Cr | -10.84 Cr |
| Net Issuance Payments Of Debt | 0.80 Cr | 0.00 | -119.82 Cr | 9.76 Cr |
| Net Short Term Debt Issuance | 0.00 | 0.00 | -119.82 Cr | 11.16 Cr |
| Short Term Debt Issuance | 0.00 | 0.00 | — | 11.16 Cr |
| Net Long Term Debt Issuance | 0.80 Cr | 0.00 | 0.00 | -1.40 Cr |
| Long Term Debt Issuance | 0.80 Cr | 0.00 | — | — |
| Investing Cash Flow | 0.00 | 0.00 | 25.09 Cr | 0.00 |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 12.19 Cr | 0.00 |
| Net PPE Purchase And Sale | 0.00 | 0.00 | 12.89 Cr | 0.00 |
| Operating Cash Flow | 0.20 Cr | 0.87 Cr | 93.76 Cr | 2.51 Cr |
| Change In Working Capital | 1.06 Cr | 2.36 Cr | 104.24 Cr | 5.26 Cr |
| Change In Other Current Liabilities | 0.10 Cr | 94000.00 | -7.75 Cr | 0.35 Cr |
| Change In Other Current Assets | -0.07 Cr | -0.06 Cr | 4.36 Cr | 0.73 Cr |
| Change In Payable | 1.05 Cr | 2.56 Cr | -8.28 Cr | 3.37 Cr |
| Change In Inventory | 0.00 | 0.00 | 35.24 Cr | 0.00 |
| Change In Receivables | -0.01 Cr | -0.16 Cr | 80.68 Cr | 0.81 Cr |
| Depreciation And Amortization | 4.07 Cr | 4.07 Cr | 4.61 Cr | 5.64 Cr |
| Depreciation | 4.07 Cr | 4.07 Cr | 4.61 Cr | 5.64 Cr |
| Net Income From Continuing Operations | -4.93 Cr | -5.55 Cr | -15.23 Cr | -19.23 Cr |
| Repayment Of Debt | — | -0.87 Cr | -119.82 Cr | -1.40 Cr |
| Short Term Debt Payments | — | 0.00 | -119.82 Cr | — |
| Long Term Debt Payments | — | -0.87 Cr | 0.00 | -1.40 Cr |
| Sale Of Investment | — | 0.00 | 12.19 Cr | 0.00 |
| Sale Of PPE | — | 0.00 | 12.89 Cr | 0.00 |
| Taxes Refund Paid | — | 0.00 | 0.00 | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | — | -1000.00 | 1000.00 |
| Net Other Investing Changes | — | — | 1000.00 | — |
| Other Non Cash Items | — | — | 0.13 Cr | 10.84 Cr |
| Issuance Of Capital Stock | — | — | — | 0.00 |
| Net Common Stock Issuance | — | — | — | 0.00 |
| Common Stock Issuance | — | — | — | 0.00 |
| Purchase Of PPE | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Kobo Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.